Showing results (211-220 of 1,273) with videos related to

Sort By:
Pageof 128
Clinical Colorectal Cancer|April 10, 2010
Nonoperative management of rectal cancer: current perspectivesKristin A Higgins, Christopher G Willett, Brian G Czito
Clinical Colorectal Cancer|April 10, 2010
The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapyChristopher Lieu, Scott Kopetz
Clinical Colorectal Cancer|March 4, 2006
Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinomaXue-guan Lu, Chun-gen Xing, Yi-zhong Feng, et al.
Clinical Colorectal Cancer|October 10, 2006
Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancerShelley Dranko, Connie Kinney, Ramesh K Ramanathan
Clinical Colorectal Cancer|July 16, 2008
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab aloneDaniel J Freeman, Todd Juan, Maureen Reiner, et al.
Clinical Colorectal Cancer|May 9, 2009
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway BiomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.
Clinical Colorectal Cancer|September 10, 2013
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancerHaiyan Zhai, Andrew Fesler, Kristina Schee, et al.
Clinical Colorectal Cancer|July 29, 2014
Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancerBert H O'Neil, Calin Cainap, Eric Van Cutsem, et al.
Clinical Colorectal Cancer|July 31, 2014
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancerEfrat Dotan, Karthik Devarajan, A James D'Silva, et al.
Clinical Colorectal Cancer|January 2, 2013
A combined analysis of mismatch repair status and thymidylate synthase expression in stage II and III colon cancerKatarina Öhrling, Mia Karlberg, David Edler, et al.
Pageof 128